key: cord-0809871-wo074afh authors: Iesa, Mohamed AM.; Osman, Makarim EM.; Hassan, Mohamed A.; Dirar, Amina IA.; Abuzeid, Nadir; Mancuso, James J.; Pandey, Ritu; Mohammed, Arwa A.; Borad, Mitesh J.; Babiker, Hani M.; Konozy, Emadeldin HE. title: SARS-COV2 and P. falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt date: 2020-11-19 journal: New Microbes New Infect DOI: 10.1016/j.nmni.2020.100817 sha: 966b75d49a793e7f77a1445f862b1adb3979833d doc_id: 809871 cord_uid: wo074afh COVID-19 has caused significant morbidity and mortality, and new cases are on the rise globally, yet malaria-endemic areas report statistically significant lower incidences. We identified potential shared targets for an immune response to SARS-CoV-2 by immune determinants shared identities with Plasmodium falciparum using IEDB’s Immune browser tool 9.0. Probable cross-reactivity is suggested through HLA-A*02:01 and subsequent CD8+ T cell activation. The apparent immunodominant epitope conservation between SARS-COV-2 (N and Orf1ab) and P. falciparum thrombospondin-anonymous-related protein (TRAP) may underlie the low COVID-19 incidence in the malaria-endemic zone by providing immunity against virus infection to those previously infected with plasmodium. Additionally, the shared epitopes lie within antigens which aid in the establishment of the P. falciparum invasion to the erythrocytes may hypothesize an alternative route for SARS-CoV-2, though yet to be proven, via erythrocyte CD147 receptor. COVID-19 (~187 625 as of 06/17/2020) compared to other regions [4] [5] [6] . The infection of malaria and the severity of the disease have shown an association with the ABO blood group system. Individuals with the O blood group are less susceptible to the infection compared to individuals with the A blood group [7] . The mechanism for this preferential protection is attributed to the rosette phenomenon which is initially induced by the parasite proteins; thrombospondin-related adhesive protein (MTRAP), and RH5. MTRAP and RH5 interact with the CD147 receptor on the erythrocyte surface which would result in making infected RBCs stickier and therefore facilitate their binding to healthy erythrocytes, to form RBC clusters termed rosettes [7, 8] . These rosettes assist parasites to escape recognition by phagocytosis. Clump formation is weakly seen in the case of individuals with O blood group. The relationship between the ABO blood groups and susceptibility to COVID-19 infection has already been documented and is shown to follow a pattern similar to that of malaria [9] . Blood group A is associated with a high risk for acquiring the disease whereas O blood group individuals have the lowest risk [10] . Several recent reports have highlighted the notably lower incidence of COVID-19 in malaria-endemic belts [11, 12] . Though no mechanistic laboratory-based clarifications of this lower number of COVID-19 cases in the African malaria zone have been explained, several hypotheses have been put forward to answer the open query; factors such as 1) the wormer continent's climate [13] , 2) the limited number of international air traffic mobility to and from Africa compared to the other continents, 3) the public socioeconomic conditions 4) the early lockdown measures, 5) the demography, 6) the protection provided by repeated use of antimalarial drugs and finally 7) factors related to host susceptibility which might include immunological and genetics factors [14] [15] [16] [17] have been widely suggested. The genome of coronaviruses encodes 16 non-structural proteins and four major structural proteins. A number of them are being targeted therapeutically and being considered for J o u r n a l P r e -p r o o f candidates for vaccine development for COVID-19 [18, 19] . In this study, we have computationally and statistically analyzed cases of COVID-19 in malaria-endemic regions and investigated possible shared immunogenic regions between dominant proteins of P. falciparum and SARS-CoV-2. We collected and analyzed data from WHO reports and countries' status profiles for malaria HBHI in 2018 and the daily reports of the COVID-19 outbreak [5, 20] . Two-tailed tests of logistic regression coupled with chi-square, odds ratio, and confidence interval analysis were performed using GraphPad Prism (Inc., San Diego, CA, 5.0). Correlation confidence was used and analysis of variance (One Way ANOVA) was performed with Bonferroni's multiple comparison tests. SARS-CoV-2 B cells and T-MHC restricted immunodominant regions and their correspondent epitopes which are potential targets for immune responses were identified by Grifoni et al [21] . These potential epitopes were determined based on sequence shared identities with the closely related SARS-CoV and by parallel bioinformatics, prediction approaches. Epitopes sequence from SARS-CoV-2 were then retrieved and used to identify common immunodominant epitopes for P. falciparum. The Immune Epitope Database and Analysis Resource (IEDB, https://www.iedb.org) is a comprehensive repository of epitope data reported from the scientific literature. It includes antibody and T cell epitopes for infectious disease, allergy, autoimmunity, and transplantation. IEDB was used to search the immunome of Plasmodium falciparum (ID 5833) to identify the most immunogenic proteins (i.e. 23 proteins were determined) and retrieve their immunodominant epitopes. These Erythrocyte binding antigen -140 (EBL-140) and Erythrocyte binding antigen-181 (EBL-181). These proteins were mapped back to the P falciparum representative reference sequence using the IEDB's Immune browser tool 9.0 to display graphs and a data table that depicts and lists all the epitopes by their position and response frequency (RF: how frequently a residue was found in a positive epitope) [22, 23] . All B and T cells epitopes for the 23 proteins displayed were selected based on their sequence RF ˃ 0.0, for extra refinement of the results we went further to identify T cell epitopes with recognition restricted by human leukocyte antigens (HLA) major histocompatibility complex (MHC) (class I (HALA-A, B) and class II (HLA-DR, DP, DQ)), and only positive assays were selected. Next, we aligned the P falciparum B cell, T cell, and T cells-MHC restriction epitopes to the SARS-CoV-2 immunodominant epitopes in order to calculate the percentage identity between each of the P falciparum dominant epitopes and SARS-CoV-2. Four and/or five amino acid shared residues were considered significant [24] . To identify and predict potential T cells MHC restricted epitopes by alternative methods for selected P. falciparum antigenic targets (AMP-1, MSP-1, CSP, TRAP, and SSP-2) and SARS-CoV-2 ORF proteins (Orf 3a, Orf 1ab, Orf 7a, Orf 8, and Orf 10). We used the IEDB MHC-I prediction tool (http://tools.iedb.org/mhcI) and MHC-II prediction tool (http://tools.iedb.org/mhcII). These tools employ different methods to determine the ability of the submitted sequence to bind to specific MHC-J o u r n a l P r e -p r o o f I and II molecules. The artificial neural network (ANN) method was used to calculate the IC50 values of the peptide binding. For both frequent and non-frequent alleles, the peptide length was set to 9 amino acids prior to the prediction. For MHC-I epitopes the alleles with affinity binding at IC50 that are equals to or less than 500 nM were considered [25] , while for MHC-II all epitopes that bind to many alleles at score equal to or less than 1000 nM at half maximum inhibitory concentration IC50 were selected for further homology analysis [26] . We obtained results of malaria (2018) falciparum and COVID-19 death rates (r 2 = -0.218, p<0.001). Bonferroni's multiple comparison tests were used to compare the mean of death rates and showed a significant variation between death rate caused by P. falciparum and P. vivax against COVID-19 (95% CI, p <0.005) ( Table 1) . We have screened the P. falciparum immunome to identify immunodominant regions. Twenty-three proteins were selected as promising immunogenic proteins. A total of 763 B- For SARS-CoV-2 ten immunodominant regions which were identified in reference to SARS-CoV, by Grifoni et al. [21] , via experimental data and confirmed with prediction approaches were used to define conserved shared regions with Plasmodium's tested immunogenic proteins. J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f All tested B-cell epitopes shared no significant homology with SARS-CoV-2. As such, no antibodies to Plasmodium could be proposed as eliciting an immune response against infection with SARS-CoV-2 through cross-reactivity. On the other hand, ≥ 40% shared identities were noticed between SARS-CoV-2 N protein (215 -227) and Plasmodium TRAP epitopes located at (509 -523), and also between Orf 1ab (3661 -3669) and TRAP (101 -130). While the phylogenetic distance between the two organisms would be expected, 4-5 shared amino acids in a single immunodominant epitope would be considered significant ( Table 2) . homologous to TRAP precursor (114 -122, RF =1) and also recognized by same HLA molecule. Experimentally, HLA-A*02:01 was assayed using INF-ϒ-ELISPOT and reported to be restricted to CD 8 + T lymphocyte response to malaria in endemic areas (Table 3) . We then analyzed the epitopes generated from the prediction approach, which resulted in the same sequences shared between TRAP epitopes and SARS-CoV (Table 4 ). The outbreak of COVID-19 caused by SARS-CoV-2 has caused significant devastation on multiple fronts with 8 061 550 total confirmed cases and 440 290 deaths globally (06/17/2020) [27] . This pandemic has adversely affected social practices, health care systems, and economies. Despite the incremental increase in incidence in various parts of the world, Africa remained the continent with the lowest number of confirmed cases and deaths. The poor socioeconomic status of Africa makes it one of the most vulnerable regions in the world due to malnutrition, endemic tropical infections, fragile health care systems, poverty, and social practices that encourage close gatherings [4] . However, the consensus is that the actual situation of the pandemic in Africa remains unclear. According to the director of Africa CDC, only 1.3 million COVID-19 tests were conducted by mid-May across the continent (one test for every 1000 individuals), compared to 3.6 million tests performed in Italy by the 27 th of May [28] . The social distancing applied by many governments in Africa to mitigate the pandemic is now creating extra financial hardship and food insecurity among African women and may not be effective in the future [29] . In endemic areas, the net immune response of one disease can be influenced by the predominant pathogen. The immune response to SARS-CoV-2 infection in malaria-endemic areas could be impacted by prior exposure to the Plasmodium parasite [31] . However, considering the immune response through cross-reactivity could also be of value. The concept of original antigenic sin is well known and had been used to explain many immunological phenomena. Essentially an adaptive immune response against one antigen can be used to combat another exposure by unrelated antigen [32] , in which the second antigen will rely on the memory established for the first antigen to initiate response [33, 34] . In T-cell cross-reactivity, closely related sequences recognition is very common and typically occurs between genetically related organisms. This is well documented for the same epitope isolated from different hepatitis C virus (HCV) strains. Each epitope had a minor variation constricted to a single amino acid change. In this case, crossreactivity occurs but with substantial differences in the priming and the magnitude of response [35] . Nonetheless, cross-reactivity can also be seen among random peptides or peptides with no shared sequences or between those bearing relativity low homology [36, 37] . Mechanism of recognition between TCR and the epitope-MHC complex where binding is not governed by the chemical principles of the epitope sequence is documented [38] . Searching the T-cell immunodominant epitopes as well as T-MHC restricted epitopes for shared sequences between P. falciparum and SARS-CoV-2 revealed several conserved tetrapeptides and pentapeptides between the two organisms. Since both organisms are evolutionarily distant, the four and five amino acids shared were considered of significance. These similarities were observed among immunodominant sequences (N protein from SARS-CoV-2/SARS-CoV and TRAP from P. falciparum) and (S protein-SARS-CoV2/SARS-CoV and predicted epitope in SSP-2 from P. falciparum). Separately, both epitopes can stimulate CD8+ T-lymphocyte response through HLA-A*02:01 recognition. In this argument, we carefully applied the doctrine of original antigenic sin to explain possible crossreactivity between SARS-CoV-2 and P. falciparum. TRAP is a type 1 membrane protein essential for sporozoite motility and cellular invasion. 21% of MHC-I restricted CD 8 + T cell epitopes are found in this protein and 28.6% -100% of subjects from malaria-endemic areas responded to 504 -GLALLACAGL-513 immunodominant epitope with restriction to HLA-A*02:01 [39] . Four amino acid determinants found in this epitope were shared by SARS-CoV-2 nucleocapsid protein 219 -LALLLLDRL-227 which recognition is also restricted by HLA-A*02:01 [21] . Our assumption here is that the memory of the cellular adaptive immunity mounted against the mentioned TRAP immunodominant epitope could recognize the 219 -LALLLLDRL-227 -HLA-A*02:01 complexes originated from SARS-CoV-2 infection in malaria-endemic regions and trigger an immune response. Of course, such an assumption needs further empirical testing to prove its validity and ascertain the strength of the primed response. Although we couldn't find any shared immunodominant epitopes between P. falciparum and SARS-CoV-2 B-cell epitopes, many recent letters to the editors suggested that antibodies against glycol-immunodeterminants upon P. falciparum infection could recognize SARS-CoV-2 envelop glycoproteins and induce activation of the complement system and the proinflammatory cytokines [40, 41] . The fatality of malaria is attributed in part to the invasion of the Plasmodium to the erythrocytes, a process mediated by RH5-CD147 interactions. Recent findings have indicated infection of the host cell by SARS-COV-2 through spike protein-CD147 interaction [42] . Though the CD147 receptor is also expressed on the erythrocyte surface, these authors focused only on the lung's receptor. Ulrich and Pillat proposed the CD147 receptor as a target for COVID-19 treatment [43] . In a recent study, homology modeling and molecular docking revealed that SARS-COV-2 could attack hemoglobin and inhibit heme metabolism. The authors also showed that the viral non-structural proteins Orf3a and Orf1ab are assisted with the viral hemoglobin attack [44] . Of COVID-19 patients admitted to ICU with acute pneumonic complications, ~49% were presented with coagulopathy and thrombotic events [45] . High levels of D dimer, fibrinolysis degraded fragments of fibrin, are often associated with COVID-19 infection and are used to detect in-hospital mortality [46, 47] , a situation that is also common with P. falciparum and P. vivax malaria [48] . Although not yet conclusively demonstrated, it's alleged that mature and immature erythrocytes could be implicated in SARS-COV-2 entry into the victim's body [49] . Both cells have CD147 and sialic acid receptors but lack ACE2 receptors. Unlike nucleated erythrocytes, mature RBCs lack the required machinery to support viral replication and to provoke an immune response through MHC molecules. Therefore, erythrocyte mediated infections are regularly mortal as they go undiscovered by the immune clearance system. Nevertheless, viruses attacking erythrocytes would attract circulating antibodies, leading to antibody clumping. This would initiate a cascade of inflammatory responses that eventually leads to blood clotting. Given that P. falciparum antigens (TRAP and SSP-2) share immunodominant epitopes with SARS-CoV-2 antigens N, S, Orf1ab, and Orf3a (Tables 2, 3 and 4), in addition to the involvement of the CD147 receptor in the invasion process of the virus to the erythrocyte, a receptor that is commonly used by P. falciparum in the blood stage, and the subsequent finding that the nano-lipid metadichol, could moderately inhibit both SARS-COV2 by blocking the ACE2 receptor, and the malarial parasite [50] , could indicate a plausible SARS-CoV-2 infection route related to the blood system. A novel coronavirus outbreak of global health concern Covid-19 -Navigating the Uncharted Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China WHO. Malaria Country Profile WHO. Coronavirus Disease (COVID-19) Dashboard The ABO blood group system and Plasmodium falciparum malaria Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting Individuals with "A" Rh-positive but not Rh-negative blood group are more vulnerable to SARS-COV-2 infection: Demographics and trend study on COVID-19 cases in Sudan Relationship between the ABO Blood Group and the COVID-19 Susceptibility Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria? Incidence of coronavirus disease (COVID-19) and countries affected by malarial infections COVID-19 pandemic in west Africa COVID-19 in Africa: Dampening the storm? Why is There Low Morbidity and Mortality of COVID-19 in Africa? Multiple drivers of the COVID-19 spread: The roles of climate, international mobility, and region-specific conditions What could explain the late emergence of COVID-19 in Africa The spike protein of SARS-CoV--a target for vaccine and therapeutic development A systematic review of SARS-CoV-2 vaccine candidates WHO. Coronavirus diseas (COVID-19) situation report 27 A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 The immune epitope database (IEDB) 3.0 The Immune Epitope Database (IEDB): 2018 update Inter-pathogen peptide sharing and original antigenic sin: Solving a paradox Immune epitope database analysis resource Immune epitope database analysis resource (IEDB-AR) Lack of COVId-19 testing underdetermines Africa's sucess COVID-19: the gendered impacts of the outbreak Analysis: Africa's unexpected COVID-19 figures Understanding the role of inflammatory cytokines in malaria and related diseases The Unspecific Side of Acquired Immunity Against Infectious Disease: Causes and Consequences Immunology and Evolution of Infectious Disease Original antigenic sin: A comprehensive review Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and crossreactivity of CD8+ T cells Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands Quantitating T cell crossreactivity for unrelated peptide antigens The multiple mechanisms of T cell receptor cross-reactivity Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role? Plasmodium falciparum Infection May Protect a Population from Severe Acute Respiratory Syndrome Coronavirus 2 Infection SARS-CoV-2 invades host cells via a novel route: CD147-spike protein CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement COVID-19:Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Covid-19 and thrombosis: what do we know about the risks and treatment? Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study D-dimer levels on admission to predict inhospital mortality in patients with Covid-19 Persistently elevated laboratory markers of thrombosis and fibrinolysis after clinical recovery in malaria points to residual and smouldering cellular damage COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review A Novel Nano Lipid Formulation that Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses in Vitro Malaria endemic zones is characterized by apparent low COVID-19 incidences silico study, possible shared immunodominant epitopes between SARS-CoV2 and P. falciparum antigens were found Probable cross-reactivity is hypothesized through HLA-A*02:01 and subsequent CD8+ T cell activation, which may eventually leads to protection against the SARS-COV-2 in the malaria-endemic zones The immunodominant epitope conservation between some of the SARS-COV-2 antigens and P. falciparum TRAP may indicate a novel route for the virus Mohamed Iesa,: Investigation; Formal analysis; Writing -Original Draft Makarim Osman: Investigation; Formal analysis; Writing -Original Draft Mohamed Hassan: Conceptualization; Data Curation Formal analysis Nadir Abuzeid : Data Curation Writing -Original Draft Formal analysis; Data Curation Writing -Original Draft; Supervision Konozy: Conceptualization; Methodology; Writing -Original Draft; Writing -Review & Editing The authors would like to thank Drs Tirdad Zangeneh, Daruka Mahadevan, and Andrew Kraft for reviewing of the manuscript